Mesodermal fate decisions of a stem cell: The Wnt switch

Cellular and Molecular Life Sciences

Volumn 65, Issue 17, 2008, Pages 2658-2674

  Davis, L A ^a   Zur Nieden, N I ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

Adipogenesis; Beta catenin; Chondrogenesis; Osteogenesis; Stem cell; Wnt signaling

Indexed keywords

TRANSCRIPTION FACTOR; WNT PROTEIN;

ADIPOGENESIS; ADULT STEM CELL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FATE; CHONDROGENESIS; EMBRYONIC STEM CELL; GENE SWITCHING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESODERM; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; MESODERM; SIGNAL TRANSDUCTION; STEM CELLS; WNT PROTEINS;

EID: 51349101105     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8042-1     Document Type: Review

References (161)

1. Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C. P., Harris, C. P., Waknitz, M. A., Itskovitz-Eldor, J. and Thomson, J. A. (2002) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271-278.
2. Rattan, S. I. S. (2003) Aging outside the body: usefulness of the Hayflick system. In Aging of cells in and outside the body SC Kaul et al., eds (Kuwer Academic, London), pp 1-8
3. Stenderup, K., Justesen, J., Clausen, C. and Kassem, M. (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919-926.
4. Evans, M. J. and Kaufman, M. H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
5. Martin, G. R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634-7638.
6. Sato, N., Sanjuan, I. M., Heke, M., Uchida, M., Naef, F. and Brivanlou, A. H. (2003) Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 260, 404-413.
7. Guasch, G. and Fuchs, E. (2005) Mice in the world of stem cell biology. Nat. Genet. 37, 1201-1206.
8. Smith, A. G. (2001) Embryo-derived stem cells: of mice and men. Annu. Rev. Cell. Dev. Biol. 17, 435-462.
9. Metcalf, D. (1990) The induction and inhibition of differentiation in normal and leukaemic cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 327, 99-109.
10. Nichols, J., Davidson, D., Taga, T., Yoshida, K., Chambers, I. and Smith, A. (1996) Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech. Dev. 57, 123-131.
11. Tighe, A. P. and Gudas, L. J. (2004) Retinoic acid inhibits leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. J. Cell. Physiol. 198, 223-229.
12. Kunath, T., Saba-El-Leil, M. K., Almousailleakh, M., Wray, J., Meloche, S. and Smith, A. (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134(16), 2895-2902.
13. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S. and Jones, J. M. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
14. Xiao, L., Yuan, X. and Sharkis, S. J. (2006) Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24, 1476-1486.
15. Ying, Q. L., Nichols, J., Chamber, I. and Smith, A. (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292.
16. Vallier, L., Alexander, M. and Pedersen, R. A. (2005) Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509.
17. Ogawa, K., Nishinakamura, R., Iwamatsu, Y., Shimosato, D. and Niwa, H. (2006) Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem. Biophys. Res. Commun. 343, 159-166.
18. Verfaillie, C. M., Pera, M. F. and Lansdorp, P. M. (2002) Stem cells: hype and reality. Hematology Am. Soc. Hematol. Educ. Program., 369-391
19. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Scholer, H. and Smith, A. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391.
20. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. and Smith, A. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
21. Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N. and Lovell-Badge, R. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes. Dev. 17, 126-140.
22. Rogers, M. B., Hosler, B. A. and Gudas, L. J. (1991) Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 113, 815-824.
23. Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenter, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., Gifford, D. K., Melton, D. A., Jaenisch, R. and Young, R. A. (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6), 947-956.
24. Loh, Y. H., Wu, Q., Chew, J. L., Vega, V. B., Zhang, W., Chen, X., Bourque, G., George, J., Leong, B., Liu, J., Wong, K. Y., Sung, K. W., Lee, C. W., Zhao, X. D., Chiu, K. P., Lipovich, L., Kuznetsov. V. A., Robson. P., Stanton. L. W., Wei. C. L., Ruan. Y., Lim. B. and Ng. H. H. (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38(4), 431-440.
25. Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., Bell, G. W., Otte, A. P., Vidal, M., Gifford, D. K., Young, R. A. and Jaenisch, R. (2006). Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091), 349-353.
26. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E. and Jaenisch, R. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324.
27. Okita, K., Ichisaka, T. and Yamanaka, S. (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448(7151), 313-317.
28. Caplan, A. I. (1991) Mesenchymal stem cells. J. Orthop. Res. 9, 641-650.
29. Johnstone, B., Hering, T. M. and Caplan, A. I. (1998) In vitro chondrogenesis of bone-marrow-derived mesenchymal progenitor cells. Exp. Cell. Res. 238, 265-272.
30. Di Rocco, G., Iachininoto, M. G., Tritarelli, A., Straino, S., Zacheo, A., Germani, A., Crea, F. and Capogrossi, M. C. (2006) Myogenic potential of adipose-tissue-derived cells. J. Cell Sci. 119, 2945-2952.
31. Wislet-Gendebien, S., Hans, G., Leprince, P., Rigo, J. M., Moonen, G. and Rogister, B. (2005) Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 23, 392-402.
32. Hou, L., Cao, H., Wang, D., Wei, G., Bai, C., Zhang, Y. and Pei, X. (2003) Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro. Int. J. Hematol. 78, 256-261.
33. Lamoury, F. M., Croitoru-Lamoury, J. and Brew, B. J. (2006) Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1. Cytotherapy 8(3), 228-242.
34. Lee, O. K., Kuo, T. K., Chen, W. M., Lee, K. D., Hsieh, S. L. and Chen, T. H. (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103, 1669-1675.
35. De Ugarte, D. A., Alfonso, Z., Zuk, P. A., Elbarbary, A., Zhu, M., Ashjian, P., Benhaim, P., Hedrick, M. H. and Fraser, J. K. (2003) Differential expression of stem cell-mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol. Lett. 89, 267-270.
36. Young, H. E., Mancini, M. L., Wright, R. P., Smith, J. C., Black, Jr. A. C., Reagan, C. R. and Lucas, P. A. (1995) Mesenchymal stem cells reside within the connective tissues of many organs. Dev. Dyn. 202, 137-144.
37. Shih, D. T., Lee, D. C., Chen, S. C., Tsai, R. Y., Huang, C. T., Tsai, C. C., Shen, E. Y. and Chiu, W. T. (2005) Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 23, 1012-1020.
38. Waller, E., Olweus, J., Lund-Johansen, F., Huang, S., Nguyen, M., Guo, G. and Terstappen, L. (1995) The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoetic and stromal progenitors. Blood 85, 2422-2435.
39. Friedenstein, A. J., Chailakhjan, R. K. and Lalykina, K. S. (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell. Tissue Kinet. 3, 393-403.
40. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J. and Horwitz, E. M. (2006). Minimum criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position. Cytotherapy, 8(4), 315-317.
41. Stenderup, K., Justesen, J., Eriksen, E. F., Rattan, S. I. and Kassem, M. (2001) Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J. Bone Miner. Res. 16, 1120-1129
42. Jones, E. A., English, A., Henshaw, K., Kinsey, S. E., Markham, A. F., Emery, P. and McGonagle, D. (2004) Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 50, 817-827.
43. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S. and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
44. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L. and Verfaillie, C. M. (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615-2625.
45. Jones, E. A., Kinsey, S. E., English, A., Jones, R. A., Straszynski, L., Meredith, D. M., Markham, A. F., Jack, A., Emery, P. and McGonagle, D. (2002) Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 46, 3349-3360.
46. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C. and Deliliers, G. L. (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp. Hematol. 30, 783-791.
47. Cormier, J., zur Nieden, N. I., Rancourt, D. E. and Kallos, M. S. (2006) Short-term expansion of murine embryonic stem cells as aggregates in suspension culture bioreactors. Tissue Eng. 12(11), 3233-3245.
48. Draper, J. S., Moore, H. D., Ruban, L. N., Gokhale, P. J. and Andrews, P. W. (2004) Culture and characterization of human embryonic stem cells. Stem Cells Dev. 13, 325-336.
49. Moon, R. T., Bowerman, B., Boutros, M. and Perrimon, N. (2002) The promise and perils of Wnt signaling through beta-catenin. Science 296, 1644-1646.
50. Miller, J. R., Hocking, A. M., Brown, J. D. and Moon, R. T. (1999) Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18, 7860-7872.
51. Huelsken, J. and Behrens, J. (2002) The Wnt signalling pathway. J. Cell Sci. 115, 3977-3978.
52. Alonso, L. and Fuchs, E. (2003) Stem cells in the skin: waste not, Wnt not. Genes. Dev. 17, 1189-1200.
53. Staal, F. J. and Clevers, H. C. (2003) Wnt signaling in the thymus. Curr. Opin. Immunol. 15, 204-208.
54. Nüsse, R. (2005) Wnt signaling in disease and in development. Cell Res. 15(1), 28-32.
55. Nelson, W. J. and Nusse, R. (1997) Convergence of Wnt, β-catenin, and cadherin pathways. Science 303, 1483-1487.
56. Bhanot, P., Brink, M., Samos, C. H., Hsieh, J. C., Wang, Y., Macke, J. P., Andrew, D., Nathans, J. and Nusse, R. (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382, 225-230.
57. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J. P. and He, X. (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407, 530-535.
58. Wehrli, M., Dougan, S. T., Caldwell, K., O'Keefe, L., Schwartz, S., Vaizel-Ohayon, D., Schejter, E., Tomlinson, A. and DiNardo, S. (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407, 527-530.
59. Pfeifer, M. and Polakis, P. (2000) Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287, 1606-1609
60. Thomas, G. M., Frame, S., Goedert, M., Nathke, I., Polakis, P. and Cohen, P. (1999) A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett. 458(2), 247-251.
61. Umbhauer, M., Djiane A., Goisset, C., Penzo-Medez, A., Riou, J. F., Boucaut, J. C. and Shi, D. L. (2000) The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signaling. Embo J 19(18), 4944-4954
62. Li, L., Yuan, H., Weaver, C. D., Mao, J., Farr, G. H. 3rd, Sussman, D. J., Jonkers, J., Kimelman, D. and Wu, D. (1999) Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J. 18(15), 4233-4240.
63. Smalley, M. J., Sara, E., Paterson, H., Naylor, S., Cook, D., Jayatilake, H., Fryer, L. G., Hutchinson, L., Fry, M. J. and Dale, T. C. (1999) Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J. 18(10), 2823-2835.
64. Logan, C. Y. and Nusse, R. (2004) The Wnt signaling pathway in development and disease. Annu. Rev. Cell. Dev. Biol. 20, 781-810.
65. Bienz, M. and Clevers, H. (2003) Armadillo/beta-catenin signals in the nucleus-proof beyond a reasonable doubt? Nat Cell Biol 5, 179-182.
66. Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P. J. and Yang, Y (2003). Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol. 162(5), 899-908.
67. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R. and Ben-Ze'ev, A. (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acd Sci USA 96, 5522-5527.
68. Eklof Spink, K., Fridman, S. G. and Weis, W. I. (2001). Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J 20(22), 6203-6212.
69. Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., Moon, R. T., Ninomiya-Tsuji, J. and Matsumoto, K. (2003) The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol. Cell. Biol. 23, 131-139.
70. Topczewski, J., Sepich, D. S., Myers, D. C., Walker, C., Amores, A., Lele, Z., Hammerschmidt, M., Postlethwait, J. and Solnica-Krezel, L. (2001) The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension. Dev. Cell 1, 251-264.
71. Axelrod, J. D., Miller, J. R., Shulman, J. M., Moon, R. T. and Perrimon, N. (1998) Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and Wingless signaling pathways. Genes Dev. 12, 2610-2622.
72. Boutros, M., Paricio, N., Strutt, D. I. and Mlodzik, M. (1998) Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 94, 109-118.
73. Wallingford, J. B., Rowning, B. A., Vogeli, K. M., Rothbacher, U., Fraser, S. E. and Harland, R. M. (2000) Dishevelled controls cell polarity during Xenopus gastrulation. Nature 405, 81-85.
74. Kuhl, M., Sheldahl, L. C., Park, M., Miller, J. R. and Moon, R. T. (2000) The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16, 279-283.
75. Yang, Y., Topol, L., Lee, H. and Wu, J. (2003) Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130, 1003-1015.
76. Haegele, L., Ingold, B., Naumann, H., Tabatabai, G., Ledermann, B. and Brandner, S. (2003) Wnt signaling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol. Cell. Neurosci. 24, 696-708.
77. Aubert, J., Dunstan, H., Chambers, I. and Smith, A. (2002) Functional gene screening in embryonic stem cells implicates wnt antagonism in neural differentiation. Nat. Biotechnol. 20, 1240-1245.
78. Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E. and Xu, Y. (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell. Biol. 7(2), 165-171
79. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. and Brivanlou, A. H. (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55-63
80. Hay, N. and Sonenberg, N. (2004). Upstream and downstream of mTOR. Genes Dev. 18(16), 1926-1945.
81. Kielman, M. F., Rindapaa, M., Gaspar, C., van Poppel, N., Breukel, C., van Leeuwen, S., Taketo, M. M., Roberts, S., Smits, R. and Fodde, R. (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat. Genet. 32, 594-605.
82. Miyabayashi, T., Teo, J. L., Yamamoto, M., McMillan, M., Nguyen, C. and Kahn, M. (2007). Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. USA. 104(13), 5668-5673.
83. Sommer, L. and Rao, M. (2002) Neural stem cells and regulation of cell number. Prog. Neurobiol. 66, 1-18
84. Tosh, D. and Slack, J. M. (2002) How cells change their phenotype. Nat. Rev. Mol. Cell. Biol. 3, 187-194
85. Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L. and MacDougald, O. A. (2000) Inhibition of adipogenesis by wnt signaling. Science 289, 950-953.
86. McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K. and Chen, C. S. (2004) Cell shape, cytoskeletal tension and RhoA regulate stem cell lineage commitment. Am. J. Physiol. 275, R 1898-1908.
87. Tuan, R. S. (2003) Cellular signaling in developmental chondrogenesis: N-cadherin, Wnts, and BMP-2. J. Bone Joint Surg. Am. 85-A Suppl 2, 137-141
88. Dani, C., Smith, A. G., Dessolin, S., Leroy, P., Staccini, L., Villageois, P., Darimont, C. and Ailhaud, G. (1997) Differentiation of embryonic stem cells into adipocytes in vitro. J. Cell Sci. 110, 1279-1285.
89. Kramer, J., Hegert, C., Guan, K., Wobus, A. M., Muller, P. K. and Rohwedel, J. (2000) Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech. Dev. 92, 193-205.
90. Phillips, B. W., Belmonte, N., Vernochet, C., Ailhaud, G. and Dani, C. (2001) Compactin enhances osteogenesis in murine embryonic stem cells. Biochem. Biophys. Res. Commun. 284, 478-484.
91. Buttery, L. D., Bourne, S., Xynos, J. D., Wood, H., Hughes, F. J., Hughes, S. P., Episkopou, V. and Polak, J. M. (2001) Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 7, 89-99.
92. zur Nieden, N. I., Kempka, G. and Ahr, H. J. (2003) In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71, 18-27.
93. zur Nieden, N. I., Kempka, G. and Ahr, H. J. (2004) Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol. 194, 257-269.
94. Leahy, A., Xiong, J. W., Kuhnert, F. and Stuhlmann, H. (1999) Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J. Exp. Zool. 284, 67-81.
95. Fehling, H. J., Lacaud, G., Kubo, A., Kennedy, M., Robertson, S., Keller, G. and Kouskoff, V. (2003) Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130, 4217-4227.
96. Orkin, S. H. and Pera, M. P. (2007). Stem cells down under - ISSCR 2007. Cell Stem Cell 1, 271-276.
97. Christy, R. J., Yang, V. W., Ntambi, J. M., Geiman, D. E., Landschulz, W. H., Friedman, A. D., Nakabeppu, Y., Kelly, T. J. and Lane, M. D. (1989) Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes. Dev. 3(9), 1323-1335.
98. Chawla, A., Schwarz, E. J., Dimaculangan, D. D. and Lazar, M. A. (1994) Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135(2), 798-800.
99. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5), 747-754.
100. Lee, M. H., Kwon, T. G., Park, H. S., Wozney, J. M. and Ryoo, H. M. (2003) BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 309(3), 689-694.
101. Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N. and de Crombrugghe, B. (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol. 17(4), 2336-2346.
102. Enomoto, H., Furuichi, T., Zanma, A., Yamana, K., Yoshida, C., Sumitani, S., Yamamoto, H., Enomoto-Iwamoto, M., Iwamoto, M. and Komori, T. (2004) Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J. Cell Sci. 117, 417-425.
103. Lecka-Czernik, B., Gubril, I., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C. and Jilka, R. L. (1999) Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J. Cell. Biochem. 74, 357-371.
104. zur Nieden, N. I., Kempka, G., Rancourt, D. E. and Ahr, H. J. (2005) Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev. Biol. 5, 1
105. Mulholland, D. J., Dedhar, S., Coetzee, G. A. and Nelson, C. C. (2005) Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr. Rev. 26, 898-915.
106. Aranda, A. and Pascual, A. (2001) Nuclear hormone receptors and gene expression Physiol. Rev. 81, 1269-1304.
107. Francis, G. A., Fayard, E., Picard, F. and Auwerx, J. (2003) Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65, 261-311.
108. Koutnikova, H. and Auwerx, J. (2001) Regulation of adipocyte differentiation. Ann. Med. 33, 556-561.
109. Otto, T. C. and Lane, M. D. (2005) Adipose development: from stem cell to adipocyte. Crit. Rev. Biochem. Mol. Biol. 40, 229-242.
110. Patel, Y. M. and Lane, M. D. (2000) Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J. Biol. Chem. 275, 17653-17660.
111. Tang, Q. Q., Otto, T. C. and Lane, M. D. (2003) CCAAT/Enhancer -binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. USA 100, 850-855.
112. Christy, R. J., Kaestner, K. H., Geiman, D. E. and Lane, M. D. (1991) CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 88, 2593-2597.
113. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. and Spiegelman, B. M. (1994) mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
114. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C. and Lehmann, J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813-819.
115. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M. and Evans, R. M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812.
116. zur Nieden, N. I., Price, F. D., Davis, L. A., Everitt, R. E. and Rancourt, D. E. (2007) Gene profiling on mixed ES cell populations reveals a biphasic role for beta-catenin in osteogenic differentiation. Mol. Endocrinol. 21(3), 674-685.
117. Kawaguchi, J., Mee, P. J. and Smith, A. G. (2005) osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 36, 758-769.
118. Billon, N., Iannarelli, P., Monteiro, M. C., Glavieux-Pardanaud, C., Richardson, W. D., Kessaris, N., Dani, C. and Dupin, E. (2007) The generation of adipocytes by the neural crest. Development 134(12), 2283-2292.
119. Xiong, C., Xie, Ch.-Q., Zhang, L., Zhang, J., Xu, K., Fu, M., Thompson, W. E., Yang, L.-Y. and Chen, Y. E. (2005) Derivation of adipocytes from human embryonic stem cells. Stem Cells Dev. 14, 671-675.
120. Benvenuti, S., Cellai, I., Luciani, P., Deledda, C., Baglioni, S., Giuliani, C., Saccardi, R., Mazzanti, B., Dal Pozzo, S., Mannucci, E., Peri, A., and Serio, M. (2007). Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J Endocrinol Invest. 30(9), RC26-30.
121. Siu, Y., Clarke, T. and Khillan, J. S. (2003) Limb bud progenitor cells induce differentiation of pluripotent embryonic stem cells into chondrogenic lineage. Differentiation 71, 578-585.
122. Noël, D., Gazit, D., Bouquet, C., Apparailly, F., Bony, C., Plence, P., Millet, V., Turgeman, G., Perricaudet, M., Sany, J. and Jorgensen, C. (2004) Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells 22(1), 74-85.
123. Goessler, U. R., Bugert, P., Bieback, K., Deml, M., Sadick, H., Hormann, K. and Riedel, F. (2005) In-vitro analysis of the expression of TGFbeta -superfamily-members during chondrogenic differentiation of mesenchymal stem cells and chondrocytes during dedifferentiation in cell culture. Cell Mol. Biol. Lett. 10(2), 345-362.
124. Nakayama, N., Duryea, D., Manoukian, R., Chow, G. and Han, C. Y. (2003) Macroscopic cartilage formation with embryonic stem-cell-derived mesodermal progenitor cells. J. Cell Sci. 116(Pt 10), 2015-2028.
125. Kitamura, S., Ohgushi, H., Hirose, M., Funaoka, H., Takakura, Y. and Ito, H. (2004) Osteogenic differentiation of human bone marrow-derived mesenchymal cells cultured on alumina ceramics. Artif. Organs. 28(1), 72-82.
126. Sottile, V., Thomson, A. and McWhir, J. (2003) In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 5, 149-155.
127. Tai, G., Polak, J. M., Bishop, A. E., Christodoulou, I. and Buttery, L. D. K. (2004) Differentiation of osteoblasts from murine embryonic stem cells by overexpression of the transcriptional factor osterix. Tissue Eng. 10, 1456-1466.
128. Yamane, T., Kunisada, T., Yamazaki, H., Era, T., Nakano, T. and Hayashi, S. I. (1997) Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 90, 3516-3523.
129. Kieslinger, M., Folberth, S., Dobreva, G., Dorn, T., Croci, L., Erben, R., Consalez, G. G. and Grosschedl, R. (2005) EBF2 regulates osteoblast-dependent differentiation of osteoclasts. Dev. Cell 9, 757-767.
130. Labbe, E., Letamendia, A. and Attisano, L. (2000) Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc. Natl. Acad. Sci. USA 97, 8358-8363.
131. Nishita, M., Hashimoto, M. K., Ogata, S., Laurent, M. N., Ueno, N., Shibuya, H. and Cho, K. W. (2000) Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403, 781-785.
132. Kahler, R. A. and Westendorf, J. J. (2003) Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J. Biol. Chem. 278, 11937-11944.
133. Michalik, L., Desvergne, B. and Wahli, W. (2004) Peroxisome-proliferator- activated receptors and cancers: complex stories. Nat. Rev. Cancer 4, 61-70.
134. He, T. C., Chan, T. A., Vogelstein, B. and Kinzler, K. W. (1999) PPARδ is an APC-regulated target of non-steroidal anti-inflammatory drugs. Cell 99, 335-345.
135. Hansen, J. B., Zhang, H., Rasmussen, T. H., Petersen, R. K., Flindt, E. N. and Kristiansen (2001) Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent cAMP signalling. J. Biol. Chem. 276, 3175-3182.
136. Fu, M., Rao, M., Bouras, T., Wang, C., Wu, K., Zhang, X., Li, Z., Yao, T. P. and Pestell, R. G. (2005) Cyclin D1 inhibits peroxisome proliferator- activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J. Biol. Chem. 280, 16934-16941.
137. Tetsu, O. and McCormick, F. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
138. Moldes, M., Zuo, Y., Morrison, R. F., Silva, D., Park, B. H., Liu, J. and Farmer, S. R. (2003) Peroxisome-proliferator-activated receptor gamma suppresses wnt-beta-catenin signalling during adipogenesis. Biochem. J. 376, 607-613
139. Bennett, C. N., Ross, S. E., Longo, K. A., Bajnok, L., Hemati, N., Johnson, K. W., Harrison, S. D. and MacDougald, O. A. (2002) Regulation of wnt signaling during adipogenesis. J. Biol. Chem. 277, 30998-31004.
140. Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D. and MacDougald, O. A. (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. USA 102, 3324-3329.
141. Rawadi, G., Vayssiere, B., Dunn, F., Baron, R. and Roman-Roman, S. (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a wnt autocrine loop. J. Bone Miner. Res. 18, 1842-1853.
142. MacDougald, O. A., Cornelius, P., Liu, R. and Lane, M. D. (1995) Insulin regulates transcription of the CCAAT/Enhancer binding protein (C/EBP) alpha, beta and delta genes in fully differentiated 3T3-L1 adipocytes. J. Biol. Chem. 270, 647-654.
143. Ross, S. E., Erickson, R. L., Hemati, N. and MacDougald, O. A. (1999) Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol. Cell. Biol. 19, 8433-8441.
144. Bandyopadhyay, G., Standaert, M., Sajan, M. P., Kanoh, Y., Miura, A., Barun, U., Kruse, F. and Leitges, M. (2004) Protein kinase C-l knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport. Mol. Endocrinol. 18, 373-383.
145. Yang, X., Jansson, P.-A., Nagaev, I., Jack, M. M., Carvalho, E., Stibrant Sunnerhagen, K., Cam, M. C., Cushman, S. W. and Smith, U. (2004) Evidence of impaired adipogenesis in insulin resistance. Biochem. Biophys. Res. Com. 317, 1045-1051
146. Akiyama, H., Lyons, J. P., Mori-Akiyama, Y., Yang, X., Zhang, R., Zhang, Z., Deng, J. M., Taketo, M. M., Nakamura, T., Behringer, R. R., McCrea, P. D. and de Crombrugghe, B. (2004) Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes. Dev. 18, 1072-1087.
147. Ryu, J. H., Kim, S. J., Kim, S. H., Oh, C. D., Hwang, S. G., Chun, C. H., Oh, S. H., Seong, J. K., Huh, T. L. and Chun, J. S. (2002) Regulation of the chondrocyte phenotype by beta-catenin. Development 129(23), 5541-5550.
148. Day, T. F., Guo, X., Garrett-Beal, L. and Yang, Y. (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750.
149. Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P. J. and Yang, Y. (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell. Biol. 162, 899-908.
150. Hartmann, C. and Tabin, C. J. (2001) Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104, 341-351.
151. Hu, H., Hilton, M. J., Tu, X., Yu, K., Ornitz, D. M. and Long, F. (2005) Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132, 49-60.
152. Hill, T. P., Spater, D., Taketo, M. M., Birchmeier, W. and Hartmann, C. (2005) Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727-738.
153. Bain, G., Muller, T., Wang, X. and Papkoff, J. (2003) Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 301, 84-91.
154. Westendorf, J. J., Kahler, R. A. and Schroeder, T. M. (2004) Wnt signaling in osteoblasts and bone disease. Gene 341, 19-39.
155. Kahler, R. A., Galindo, M., Lian, J., Stein, G. S., van Wijnen, A. J. and Westendorf, J. J. (2006) Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J. Cell. Biochem. 97, 969-983.
156. Bruhn, L., Munnerlyn, A. and Grosschedl, R. (1997) ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes. Dev. 11, 640-653.
157. El-Tanani, M., Fernig, D. G., Barraclough, R., Green, C. and Rudland, P. (2001) Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. J. Biol. Chem. 276, 41675-41682.
158. Boland, G. M., Perkins, G., Hall, D. J. and Tuan, R. S. (2004) Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J. Cell. Biochem. 93, 1210-1230.
159. Kalajzic, I., Staal, A., Yang, W. P., Wu, Y., Johnson, S. E., Feyen, J. H., Krueger, W., Maye, P., Yu, F., Zhao, Y., Kuo, L., Gupta, R. R., Achenie, L. E., Wang, H. W., Shin, D. G. and Rowe, D. W. (2005) Expression profile of osteoblast lineage at defined stages of differentiation. J. Biol. Chem. 280, 24618-24626.
160. Monaghan, H., Bubb, V. J., Sirimujalin, R., Millward-Sadler, S. J. and Salter, D. M. (2001) Adenomatous polyposis coli (APC), beta-catenin, and cadherin are expressed in human bone and cartilage. Histopathology 39, 611-619.
161. Rodda, S. J. and McMahon, A. P. (2006) Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231-3244.